Veradigm

Veradigm Operating Cash Flow

The Operating Cash Flow of Veradigm (MDRX) as of Nov 4, 2026 is 115.56 M USD. In the previous year, Operating Cash Flow was 115.56 M USD — a change of 0.00% (lower).

Operating Cash Flow

115.56 MUSD

YoY

0.00%

Last updated:

Operating Cash Flow of Veradigm is 2024 115.56 M USD. Operating Cash Flow of Veradigm was 2023 115.56 M USD. It decreases by 0.00% lower compared to the previous year.

The Veradigm Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2016
269.00 M USD
Jan 1, 2017
279.42 M USD
Jan 1, 2018
67.90 M USD
Jan 1, 2019
46.25 M USD
Jan 1, 2020
-106.72 M USD
Jan 1, 2021
-75.43 M USD
Jan 1, 2022
115.56 M USD
Jan 1, 2024
115.56 M USD
The Veradigm Operating Cash Flow history
YEAROperating Cash FlowYoY
115.56 MUSD0.00%
115.56 MUSD-253.21%
-75.43 MUSD-29.32%
-106.72 MUSD-330.72%
46.25 MUSD-31.88%
67.90 MUSD-75.70%
279.42 MUSD+3.87%
269.00 MUSD+27.14%
211.58 MUSD+104.43%
103.50 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Veradigm Stock analysis

What does Veradigm do? Allscripts Healthcare Solutions Inc is one of the leading companies in the digital healthcare sector in the USA. The company was founded in 1982 and has since become one of the most important providers of IT solutions in healthcare. Allscripts supports healthcare providers in improving patient care and efficiency through the development and provision of innovative software and IT solutions. The business model of Allscripts is based on the development and sale of web-based software solutions for medical documentation and hospital management. These solutions are mainly distributed to hospitals and practices through subscriptions or licenses. Allscripts offers a variety of products that focus on various areas of medical care. One of the main divisions of the company is the electronic health records system (EHR). This system allows for the electronic recording, storage, and management of medical data and information. This enables healthcare providers to quickly and easily access patient information and document important diagnoses and treatments. Another important division of Allscripts is the Revenue Cycle Management (RCM), which optimizes billing and payment processes in hospitals and practices. In addition, Allscripts also offers solutions for telemedicine, including patient portal applications, remote patient monitoring systems, and mobile apps for patients and providers. Allscripts is based in Chicago and employs over 10,000 employees in various countries. The company also maintains partnerships with other companies in healthcare to facilitate and improve the complexity of digital transformation in the healthcare market. This includes companies like Microsoft, who work together with Allscripts on the development of artificial intelligence for healthcare applications. Allscripts' portfolio of offerings is very broad and provides customers with a variety of software solutions for different areas of medical care. The products are particularly characterized by their user-friendly interfaces, flexibility, and scalability. This allows customers to customize the solutions to their specific needs and consider future requirements. However, some products have been criticized for their expandability, poor design, and slow loading times. Recently, Allscripts has made a number of investments in research and development to address these issues and optimize the applications. In summary, Allscripts Healthcare Solutions Inc is considered one of the leading providers of software and IT solutions in healthcare in the USA. Thanks to a wide range of products and close collaboration with partners in healthcare, Allscripts is able to offer its customers innovative and scalable solutions that help them optimize their business processes and improve the quality of their medical care. Veradigm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Veradigm stock

Operating Cash Flow of Veradigm is 115.56 M USD in 2024.

Operating Cash Flow of Veradigm changed from 115.56 M USD to 115.56 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Veradigm since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Veradigm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Veradigm

All Key Metrics — Veradigm